Sun Pharma Advanced Research Company Limited

SPARC.NS · NSE

Price₹0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders75.1%

Institutions1.8%

Public / Other

Quarterly Resultsin ₹ Cr

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Total money the company brought in from its core business during the quarter, before any costs are subtracted.	₹40.00 Cr	₹1,853.00 Cr	₹8.00 Cr	₹8.00 Cr	₹10.00 Cr	₹27.00 Cr	₹15.00 Cr	₹13.00 Cr	₹17.00 Cr	₹17.00 Cr	₹14.00 Cr	₹21.00 Cr
How much sales grew (or shrank) compared to the same quarter a year earlier — a cleaner read on momentum than comparing to the prior quarter, which can be skewed by seasonality.	+300.0%	+6763.0%	-46.7%	-38.5%	-41.2%	+58.8%	+7.1%	-38.1%	–	–	–	–
Total operating costs for the quarter — everything subtracted from sales to arrive at operating profit.	₹74.00 Cr	₹80.00 Cr	₹65.00 Cr	₹74.00 Cr	₹62.00 Cr	₹80.00 Cr	₹89.00 Cr	₹116.00 Cr	₹110.00 Cr	₹122.00 Cr	₹116.00 Cr	₹113.00 Cr
Sales minus expenses — profit from core operations before depreciation, interest, and tax.	-₹34.00 Cr	₹1,773.00 Cr	-₹57.00 Cr	-₹66.00 Cr	-₹52.00 Cr	-₹53.00 Cr	-₹74.00 Cr	-₹103.00 Cr	-₹93.00 Cr	-₹106.00 Cr	-₹103.00 Cr	-₹91.00 Cr
Operating profit as a percentage of sales — how much of each rupee of sales the core business keeps before depreciation, interest, and tax.	-85.0%	96.0%	-670.0%	-836.0%	-540.0%	-196.0%	-494.0%	-800.0%	-555.0%	-639.0%	-740.0%	-432.0%
Income from outside core operations — investment gains, interest earned, asset sales, one-time items. A large share of profit coming from here (rather than the core business) is worth noticing.	₹24.00 Cr	₹2.00 Cr	-₹12.00 Cr	₹0.00 Cr	₹9.00 Cr	₹0.00 Cr	₹0.00 Cr	₹0.00 Cr	₹2.00 Cr	₹4.00 Cr	₹6.00 Cr	₹8.00 Cr
Exceptional items	₹0.00 Cr	₹0.00 Cr	-₹12.36 Cr	₹0.00 Cr	₹0.00 Cr	₹0.00 Cr	₹0.00 Cr	₹0.00 Cr	₹0.00 Cr	₹0.00 Cr	₹0.00 Cr	₹0.00 Cr
Other income normal	₹23.66 Cr	₹1.80 Cr	₹0.00 Cr	₹0.01 Cr	₹9.14 Cr	₹0.00 Cr	₹0.19 Cr	₹0.04 Cr	₹1.56 Cr	₹4.40 Cr	₹6.39 Cr	₹8.49 Cr
The cost of servicing the company's debt during the period.	₹8.00 Cr	₹12.00 Cr	₹9.00 Cr	₹8.00 Cr	₹6.00 Cr	₹5.00 Cr	₹3.00 Cr	₹1.00 Cr	₹1.00 Cr	₹1.00 Cr	₹0.00 Cr	₹0.00 Cr
The non-cash accounting charge that spreads the cost of long-lived assets (equipment, buildings, intangibles) over their useful life.	₹2.00 Cr	₹2.00 Cr	₹3.00 Cr	₹3.00 Cr	₹3.00 Cr	₹3.00 Cr	₹3.00 Cr	₹3.00 Cr	₹3.00 Cr	₹3.00 Cr	₹3.00 Cr	₹3.00 Cr
Profit after all operating costs, other income, interest, and depreciation — but before tax is subtracted.	-₹21.00 Cr	₹1,761.00 Cr	-₹80.00 Cr	-₹76.00 Cr	-₹52.00 Cr	-₹61.00 Cr	-₹79.00 Cr	-₹107.00 Cr	-₹96.00 Cr	-₹105.00 Cr	-₹100.00 Cr	-₹86.00 Cr
Tax paid as a percentage of pre-tax profit. A rate well below the normal corporate rate can mean a one-time tax benefit rather than a durable advantage.	1.0%	0.0%	0.0%	0.0%	0.0%	-1.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
The company's bottom-line profit for the quarter after all expenses, interest, depreciation, and taxes are subtracted.	-₹21.00 Cr	₹1,761.00 Cr	-₹80.00 Cr	-₹76.00 Cr	-₹52.00 Cr	-₹60.00 Cr	-₹80.00 Cr	-₹107.00 Cr	-₹96.00 Cr	-₹106.00 Cr	-₹100.00 Cr	-₹86.00 Cr
Net profit as a percentage of sales — how much of each rupee of sales ultimately becomes bottom-line profit.	-52.5%	95.0%	-1000.0%	-950.0%	-520.0%	-222.2%	-533.3%	-823.1%	-564.7%	-623.5%	-714.3%	-409.5%
Net profit divided by the number of shares outstanding for the quarter — profit attributable to each share.	₹-0.64	₹54.27	₹-2.48	₹-2.34	₹-1.60	₹-1.84	₹-2.45	₹-3.31	₹-2.96	₹-3.26	₹-3.07	₹-2.66

Income Statementin ₹ Cr

	TTM	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	₹1,909.00 Cr	₹1,879.00 Cr	₹72.00 Cr	₹76.00 Cr	₹239.00 Cr
Earnings before interest, taxes, depreciation, and amortization — profit from core operations before those items, often used to compare companies regardless of how they're financed or how much they depreciate.	₹1,617.00 Cr	₹1,599.00 Cr	-₹323.00 Cr	-₹402.00 Cr	-₹214.00 Cr
The non-cash accounting charge that spreads the cost of long-lived assets (equipment, buildings, intangibles) over their useful life.	₹10.00 Cr	₹10.00 Cr	₹12.00 Cr	₹13.00 Cr	₹12.00 Cr
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	₹1,607.00 Cr	₹1,589.00 Cr	-₹335.00 Cr	-₹415.00 Cr	-₹226.00 Cr
Operating income as a percentage of revenue.	84.2%	84.6%	-465.3%	-546.1%	-94.6%
Income from outside core operations — investment gains, interest earned, asset sales, one-time items. A large share of profit coming from here (rather than the core business) is worth noticing.	₹13.00 Cr	-₹2.00 Cr	₹2.00 Cr	₹29.00 Cr	₹11.00 Cr
Exceptional items	–	-₹12.13 Cr	₹0.03 Cr	₹0.58 Cr	-₹0.11 Cr
Other income normal	–	₹10.47 Cr	₹1.76 Cr	₹28.89 Cr	₹10.88 Cr
The cost of servicing the company's debt during the period.	₹36.00 Cr	₹34.00 Cr	₹9.00 Cr	₹2.00 Cr	₹8.00 Cr
Profit after all operating costs, other income, interest, and depreciation — but before tax is subtracted.	₹1,584.00 Cr	₹1,553.00 Cr	-₹343.00 Cr	-₹387.00 Cr	-₹223.00 Cr
Tax paid as a percentage of pre-tax profit. A rate well below the normal corporate rate can mean a one-time tax benefit rather than a durable advantage.	–	0.0%	0.0%	0.0%	0.0%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	₹1,584.00 Cr	₹1,553.00 Cr	-₹343.00 Cr	-₹387.00 Cr	-₹223.00 Cr
Net income divided by the number of shares outstanding — profit attributable to each share.	₹48.81	₹47.86	₹-10.55	₹-11.93	₹-6.86

Balance Sheetin ₹ Cr

	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Physical, long-lived assets used in the business — property, plant, equipment.	₹85.00 Cr	₹99.00 Cr	₹108.00 Cr	₹106.00 Cr
Financial investments the company holds — securities, stakes in other entities, and similar holdings.	₹0.00 Cr	₹0.00 Cr	₹2.00 Cr	₹291.00 Cr
Everything else the company owns that isn't fixed assets or investments — includes cash, receivables, and inventory, which this data source doesn't break out separately.	₹2,014.00 Cr	₹183.00 Cr	₹362.00 Cr	₹406.00 Cr
Everything the company owns that has value — cash, property, inventory, investments, and more.	₹2,171.00 Cr	₹336.00 Cr	₹515.00 Cr	₹830.00 Cr
All of the company's interest-bearing borrowings, short and long term combined.	₹559.00 Cr	₹269.00 Cr	₹61.00 Cr	₹16.00 Cr
Everything the company owes that isn't interest-bearing debt — payables, provisions, and other obligations.	₹273.00 Cr	₹284.00 Cr	₹328.00 Cr	₹302.00 Cr
Everything the company owes — debt, unpaid bills, and other obligations.	₹2,171.00 Cr	₹336.00 Cr	₹515.00 Cr	₹830.00 Cr
The face value of shares issued to shareholders — the smaller, more static part of shareholders' equity (see Reserves for the larger, accumulated part).	₹32.00 Cr	₹32.00 Cr	₹32.00 Cr	₹32.00 Cr
Accumulated retained profits and other reserves built up over the company's history — usually the bulk of shareholders' equity.	₹1,306.00 Cr	-₹249.00 Cr	₹93.00 Cr	₹480.00 Cr
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	₹1,338.00 Cr	-₹217.00 Cr	₹125.00 Cr	₹512.00 Cr

Cash Flow Statementin ₹ Cr

	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-₹239.00 Cr	-₹360.00 Cr	-₹429.00 Cr	-₹69.00 Cr
Cash spent on or received from investments — buying/selling physical assets, securities, or other businesses. Usually negative for a growing company (it's spending to invest).	-₹23.00 Cr	₹158.00 Cr	₹392.00 Cr	-₹548.00 Cr
Cash flow from raising or repaying capital — issuing/repurchasing shares, taking on or repaying debt, paying dividends.	₹261.00 Cr	₹199.00 Cr	₹42.00 Cr	₹617.00 Cr
The total change in the company's cash balance during the period — operating, investing, and financing cash flow combined.	-₹1.00 Cr	-₹3.00 Cr	₹5.00 Cr	-₹1.00 Cr
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	-₹262.00 Cr	-₹370.00 Cr	-₹455.00 Cr	-₹84.00 Cr

	You	Peer avg
P/E	4.1	59.2
Revenue Growth	+314.1%	+21.4%

Sun Pharma Advanced Research Company Limited

Price History

Volume & Moving Averages

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Related Market Insights

Sun Pharma's $11.75 Billion Acquisition of Organon Marks a Landmark Pharma Deal

Sun Pharma Announces $11.75 Billion Acquisition of Organon in Major Healthcare M&A Deal

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Quarterly Resultsin ₹ Cr

Income Statementin ₹ Cr

Balance Sheetin ₹ Cr

Cash Flow Statementin ₹ Cr

Peer Comparison